Chargement en cours...
Cytotoxic Chemotherapy and CD4+ Effector T Cells: An Emerging Alliance for Durable Antitumor Effects
Standard cytotoxic chemotherapy can initially achieve high response rates, but relapses often occur in patients and represent a severe clinical problem. As increasing numbers of chemotherapeutic agents are found to have immunostimulatory effects, there is a growing interest to combine chemotherapy a...
Enregistré dans:
| Auteurs principaux: | , |
|---|---|
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
Hindawi Publishing Corporation
2012
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3286900/ https://ncbi.nlm.nih.gov/pubmed/22400040 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2012/890178 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|